Search
Displaying 561–570 of 726 for “retinal diseases”
-
ARVO 2014: European Collaboration Developing Cross-Cutting, Vision-Saving Therapies
Research NewsSimply put, they’re creating therapies that can save vision in as many people as possible, independent of the genetic cause of disease.
-
Turning Stem Cells Into "Super" Models
Research NewsScientists have found a way to take a small skin or blood sample from a patient, turn back the clock on those sample cells so they become stem cells, and then coax them forward to become photoreceptors, or any other cell type in the body.
-
The Foundation's 5 Most Asked Questions About Clinical Trials
Research NewsWhat you need to know (and what to expect) about clinical trials.
-
Research News
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
-
New England Vision Connection with Hope in Focus
- Oct 24, 2026
- 1:00 p.m. - 3:00 p.m. (EDT)
- 350 Trolley Line Blvd, Mashantucket, CT 06338
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering across the Foundation Chapter network for the blind and low vision community.
-
- Nov 4, 2026
- 6:00 p.m. (EDT)
- 11038 Bellflower Rd, Cleveland, OH 44106
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering across the Foundation Chapter network for the blind and low vision community.
-
Every voice strengthens our movement. By joining our advocacy network, you’ll receive updates on the latest policy developments, alerts when action is needed, and stories of impact from advocates nationwide. Together, we can shape policies that accelerate treatment and cures, and improve the lives of millions living with blinding diseases.
-
Beacon's emerging XLRP gene therapy improves low-light vision in phase 3 trial
Research NewsBeacon plans to begin a rolling FDA submission for laru-zova later this year
-
Leber Congenital Amaurosis Research Advances
Research NewsRecent developments in research on Leber congenital amaurosis.
-
Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment
Research NewsDeal marks another step as gildeuretinol advances towards patients
.jpg)
